UB Paderborn / Katalog / Suche / in CDI

Multiple sclerosis in 2023: beyond the boundaries

Lancet neurology, 2024-01, Vol.23 (1), p.22-24

2024

Link zum Volltext

Verfügbarkeit prüfen

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

Lancet neurology, 2021-08, Vol.20 (8), p.653-670

2021

Link zum Volltext

Verfügbarkeit prüfen

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Nature reviews. Neurology, 2020-03, Vol.16 (3), p.171-182

2020

Link zum Volltext

Verfügbarkeit prüfen

Sex and gender issues in multiple sclerosis

Therapeutic advances in neurological disorders, 2013-07, Vol.6 (4), p.237-248

2013

Link zum Volltext

Verfügbarkeit prüfen

Radiologically isolated syndrome: 5-year risk for an initial clinical event

PloS one, 2014-03, Vol.9 (3), p.e90509-e90509

2014

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

Nature reviews. Neurology, 2015-10, Vol.11 (10), p.597

2015

Link zum Volltext

Verfügbarkeit prüfen

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

Annals of neurology, 2016-02, Vol.79 (2), p.288-294

2016

Link zum Volltext

Verfügbarkeit prüfen

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

Multiple sclerosis, 2018-02, Vol.24 (2), p.214-221

2018

Link zum Volltext

Verfügbarkeit prüfen

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Multiple Sclerosis Journal, 2023-07, Vol.29 (8), p.904-925

2023

Link zum Volltext

Verfügbarkeit prüfen

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

European journal of neurology, 2023-08, Vol.30 (8), p.2144-2176

2023

Link zum Volltext

Verfügbarkeit prüfen

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Lancet neurology, 2019-02, Vol.18 (2), p.185-197

2019

Link zum Volltext

Verfügbarkeit prüfen

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

Annals of neurology, 2010-02, Vol.67 (2), p.159-169

2010

Link zum Volltext

Verfügbarkeit prüfen

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event

Multiple sclerosis, 2022-01, Vol.28 (1), p.71-81

2022

Link zum Volltext

Verfügbarkeit prüfen

Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome

Neuroradiology, 2019-06, Vol.61 (6), p.667-674

2019

Link zum Volltext

Verfügbarkeit prüfen

Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients

Multiple sclerosis, 2018-03, Vol.24 (3), p.322-330

2018

Link zum Volltext

Verfügbarkeit prüfen

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Lancet neurology, 2020-03, Vol.19 (3), p.234-246

2020

Link zum Volltext

Verfügbarkeit prüfen

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

Multiple sclerosis, 2021-05, Vol.27 (6), p.913-921

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic decisions in multiple sclerosis: moving beyond efficacy

JAMA neurology, 2013-10, Vol.70 (10), p.1315

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Therapeutic Advances in Neurological Disorders, 2023-01, Vol.16, p.17562864231180734-17562864231180734

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Multiple sclerosis in 2023: beyond the boundaries

2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

Sex and gender issues in multiple sclerosis

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Radiologically isolated syndrome: 5-year risk for an initial clinical event

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event

Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple Sclerosis

Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome

Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

Therapeutic decisions in multiple sclerosis: moving beyond efficacy

Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset

Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis

Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method

Suchergebnisse filtern